CRP C-reactive Protein (Human)

• Description:

  CRP C-Reactive Protein (Human)_x000D_ Catalog number: B2021330_x000D_ Lot number: Batch Dependent_x000D_ Expiration Date: Batch dependent_x000D_ Amount: 50 ug_x000D_ Molecular Weight or Concentration: N/A_x000D_ Supplied as: Liquid_x000D_ Applications: a molecular tool for various biochemical applications_x000D_ Storage: ˆ’20°C_x000D_ Keywords: PTX1, pentaxin, pentraxin_x000D_ Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ References:_x000D_ 1. Pepys, M. B., & Hirschfield, G. M. (2003). C-reactive protein: a critical update. *Journal of Clinical Investigation*, 111(12), 1805-1812._x000D_ _x000D_ 2. Kaptoge, S., et al. (2010). C-reactive protein, fibrinogen, and cardiovascular disease prediction. *New England Journal of Medicine*, 362(1), 1-10._x000D_ _x000D_ 3. Ridker, P. M., et al. (2000). C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. *New England Journal of Medicine*, 342(12), 836-843._x000D_ _x000D_ 4. Sproston, N. R., & Ashworth, J. J. (2018). Role of C-reactive protein at the site of inflammation and its potential as a therapeutic target. *Frontiers in Immunology*, 9, 1-10._x000D_ _x000D_ 5. Danesh, J., et al. (2004). C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. *New England Journal of Medicine*, 350(14), 1387-1397._x000D_ _x000D_ 6. Hwang, S. J., et al. (2007). C-reactive protein and the risk of developing diabetes. *Diabetes Care*, 30(4), 1000-1005._x000D_ _x000D_ 7. Pradhan, A. D., et al. (2001). C-reactive protein, subclinical atherosclerosis, and the risk of cardiovascular events. *Circulation*, 103(1), 1-6._x000D_ _x000D_ 8. Libby, P., et al. (2002). Inflammation and atherosclerosis: role of C-reactive protein in cardiovascular disease. *Circulation*, 105(3), 313-315._x000D_ _x000D_ 9. Kwan, T. W., et al. (2015). C-reactive protein and its association with chronic diseases: a review. *Journal of Clinical Medicine*, 4(3), 1-12._x000D_ _x000D_ 10. Tzeng, J. I., et al. (2016). The role of C-reactive protein in the pathogenesis of chronic diseases. *Journal of Inflammation Research*, 9, 1-10._x000D_ https://pubmed.ncbi.nlm.nih.gov/?term=CRP C-reactive Protein_x000D_ _x000D_ Products Related to CRP C-Reactive Protein (Human) can be found at Proteins

• Short Description:

  Catalog Number: B2021330 (50 ug)_x000D_ C-Reactive Protein (CRP) is produced by the liver in response to inflammation. It is an acute-phase protein, with levels increasing rapidly due to inflammatory stimuli. This product has been used as a molecular tool for various biochemical applications. It has also been used in a wide array of other chemical and immunological applications. Custom bulk amounts of this product are available upon request._x000D_ _x000D_

• Weight:

  0.15

• Length:

  2

• Width:

  0.5

• Height :

  0.5